Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment

References

• Deering D, Frampton C, Horn J, Sellman D, Adamson S, Potiki T. Health status of clients receiving methadone maintenance treatment using the SF-36 health survey questionnaire. Drug Alcohol Rev 2004; 23: 273–280
   PubMed Web of Science ®Google Scholar
• Ryan C F, White J M. Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction 1996; 91: 39–45
   PubMed Web of Science ®Google Scholar
• Scheutz F. Dental health in a group of drug addicts attending an addiction-clinic. Commun Dent Health Oral Epidemiol 1984; 12: 23–28
   PubMed Web of Science ®Google Scholar
• Sheridan J, Wheeler A, Walters C. Health problems and help-seeking activities of methadone maintenance clients at Auckland Methadone Service (AMS): potential for community pharmacy service expansion?. Harm Reduct J 2005; 2, doi:10.1186/1477–7517–2–25
   Google Scholar
• Zador D, Lyons Wall P M, Webster I. High sugar intake in a group of women on methadone maintenance in south western Sydney, Australia. Addiction 1996; 91: 1053–1061
   PubMed Web of Science ®Google Scholar
• Best D, Gossop M, Lehmann P, Marsden J, Farrell M, Strang J. Eating too little, smoking and drinking too much: wider lifestyle problems among methadone maintenance patients. Addict Res 1998; 6: 489–498
   Web of Science ®Google Scholar
• Cicero T J, Bell R D, Wiest W G, Allison J H, Polakoski K, Robins E. Function of the male sex organs in heroin and methadone users. N Engl J Med 1975; 292: 882–887
   PubMed Web of Science ®Google Scholar
• Johnson R E, Jaffe J H, Fudala P J. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992; 267: 2750–2755
   PubMed Web of Science ®Google Scholar
• Kreek M J. Medical safety and side effects of methadone in tolerant individuals. JAMA 1973; 223: 665–668
   PubMed Web of Science ®Google Scholar
• Langrod J, Lowinson J, Ruiz P. Methadone treatment and physical complaints: a clinical analysis. Int J Addict 1981; 16: 947–952
   PubMed Web of Science ®Google Scholar
• Lofwall M R, Stitzer M L, Bigelow G E, Strain E C. Comparative safety and side effect profiles of buprenorphine and methadone in the outpatient treatment of opioid dependence. Addict Dis Treat 2005; 4: 49–64
   Google Scholar
• Mattick R P, Ali R, White J M, O'Brien S, Wolk S, Danz C. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003; 98: 441–452
   PubMed Web of Science ®Google Scholar
• Ezard N, Lintzeris N, Odgers P, et al. An evaluation of community methadone services in Victoria, Australia: results of a client survey. Drug Alcohol Rev 1999; 18: 417–423
   Web of Science ®Google Scholar
• Fischer B, Chin A T, Kuo I, Kirst M, Vlahov D. Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Subst Use Misuse 2002; 37: 495–522
   PubMed Web of Science ®Google Scholar
• Mattick R P, Digiusto E, Doran C M, et al. National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD): report of results and recommendations. National Drug and Alcohol Research Centre, Sydney 2001, Monograph Series no. 52
   Google Scholar
• Australian Institute of Health and Welfare (AIHW). Alcohol and other drug treatment services in Australia 2004–05: report on the National Minimum Data Set. AIHW, Canberra 2006, Drug Treatment Series no. 5. AIHW cat. no. HSE 43
   Google Scholar
• Winstock A R, Lea T, Sheridan J. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales. Int J Drug Policy, Australia 2007, in press: doi: 10.1016/j.drugpo.2007.1003.1002
   Google Scholar
• Caplehorn J RM, Bell J, Kleinbaum D G, Gebski V J. Methadone dose and heroin use during maintenance treatment. Addiction 1993; 88: 119–124
   PubMed Web of Science ®Google Scholar
• Donny E C, Walsh S L, Bigelow G E, Eissenberg T, Stitzer M L. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology 2002; 161: 202–212
   PubMed Web of Science ®Google Scholar
• National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey National Data Report 2001–2005. National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney 2006
   Google Scholar
• Ross J, Teesson M, Darke S, et al. The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2005; 24: 411–418
   PubMed Web of Science ®Google Scholar
• Titsas A, Ferguson M M. Impact of opioid use on dentistry. Aust Dent J 2002; 47: 94–98
   PubMed Web of Science ®Google Scholar
• Charnock S, Owen S, Brookes V, Williams M. A community based programme to improve access to dental services for drug users. Br Dent J 2004; 196: 385–388
   PubMed Web of Science ®Google Scholar
• Sheridan J, Carson T, Aggleton M. Providing dental health services to drug users: testing a model for a community pharmacy advice and referral scheme. Pharm J 2003; 271: 180–182
   Web of Science ®Google Scholar
• Gray D, Spence D. The prevalence of constipation in patients receiving methadone maintenance treatment for opioid dependency. J Subst Use 2005; 10: 397–401
   Google Scholar
• Yuan C S, Foss J F, O'Connor M, Moss J, Roizen M F. Gut motility and transit changes in patients receiving long-term methadone maintenance. J Clin Pharmacol 1998; 38: 931–935
   PubMed Web of Science ®Google Scholar
• Bliesener N, Albrecht A, Schwager A, Weckbecker K, Lichtermann D, Klingmuller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 2005; 90: 203–206
   PubMed Web of Science ®Google Scholar